Related Experiment Video
Updated: Aug 16, 2025
13:45
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
10.0K
T-Cell Mediated Immunity in Merkel Cell Carcinoma
Kelsey Ouyang1,2, David X Zheng3, George W Agak1
1Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Cancers
|December 23, 2022
Summary
Merkel cell carcinoma (MCC), a rare skin cancer, is linked to UV exposure or MCPyV. Tumor-infiltrating lymphocytes (T-cells) significantly impact MCC outcomes and immune responses, guiding future immunotherapies.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer.
- MCC arises from MCC polyomavirus (MCPyV) DNA or chronic UV radiation-induced mutations.
- Metastasis commonly occurs in lymph nodes, liver, lungs, bone, and brain.
Purpose of the Study:
- To review the role of tumor-infiltrating lymphocytes (TILs) in Merkel cell carcinoma.
- To explore the impact of CD4+, CD8+, and regulatory T-cell (Tregs) responses on MCC progression.
- To discuss T-cell involvement in MCPyV-specific immunity and potential immunotherapies.
Main Methods:
- Literature review of existing studies on T-cell responses in MCC.
- Analysis of the relationship between TILs, MCPyV status, and patient survival.
- Discussion of T-cell subsets (CD4+, CD8+, Tregs) and their functions in MCC.
Main Results:
- High TIL counts correlate with favorable survival in MCC, irrespective of MCPyV presence.
- MCPyV infection may enhance T-cell infiltration into tumors.
- T-cells play a crucial role in anti-tumor immunity against MCC.
Conclusions:
- T-cell responses, including CD4+, CD8+, and Tregs, are critical in managing MCC.
- Understanding T-cell dynamics is key for developing effective MCC immunotherapies.
- Further research into T-cell biology can uncover novel therapeutic strategies for MCC.
Related Concept Videos
01:40Cell-mediated Immune Responses
69.7K
Overview
69.7K
01:27Tumor Immunotherapy
624
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
624
01:22T Cell Activation and Clonal Selection
2.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
2.6K
01:27Cytotoxic T Cells-mediated Immune Response
1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
01:24T Cell Types and Functions
1.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.2K
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K